These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15313838)

  • 1. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.
    Jennings DL; Seibyl JP; Oakes D; Eberly S; Murphy J; Marek K
    Arch Neurol; 2004 Aug; 61(8):1224-9. PubMed ID: 15313838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
    Løkkegaard A; Werdelin LM; Friberg L
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1623-9. PubMed ID: 12458397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease?
    Bhidayasiri R
    Rev Neurol Dis; 2006; 3(1):19-22. PubMed ID: 16596082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multimodal SPECT and MRT imaging data analysis for an improvement in the diagnosis of idiopathic Parkinson's syndrome].
    Barthel H; Müller U; Wächter T; Slomka P; Dannenberg C; Murai T; Kahn T; Georgi P
    Radiologe; 2000 Oct; 40(10):863-9. PubMed ID: 11103409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How useful is [123I]beta-CIT SPECT in clinical practice?
    Eerola J; Tienari PJ; Kaakkola S; Nikkinen P; Launes J
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1211-6. PubMed ID: 16107353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.
    Albert NL; Unterrainer M; Diemling M; Xiong G; Bartenstein P; Koch W; Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu LÖ; Kluge A; Ziebell M; Darcourt J; Nobili F; Pagani M; Sabri O; Hesse S; Borght TV; Van Laere K; Tatsch K; la Fougère C
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1315-22. PubMed ID: 26780619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interobserver agreement in the visual and semi-quantitative analysis of the 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome].
    Suárez-Piñera M; Prat ML; Mestre-Fusco A; Fuertes J; Mojal S; Balaguer E
    Rev Esp Med Nucl; 2011; 30(4):229-35. PubMed ID: 21524823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
    J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.
    Catafau AM; Tolosa E;
    Mov Disord; 2004 Oct; 19(10):1175-82. PubMed ID: 15390019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
    Marshall VL; Reininger CB; Marquardt M; Patterson J; Hadley DM; Oertel WH; Benamer HT; Kemp P; Burn D; Tolosa E; Kulisevsky J; Cunha L; Costa D; Booij J; Tatsch K; Chaudhuri KR; Ulm G; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2009 Mar; 24(4):500-8. PubMed ID: 19117369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an automated morphological MRI-based (123)I-FP-CIT SPECT evaluation method.
    Perlaki G; Szekeres S; Orsi G; Papp L; Suha B; Nagy SA; Doczi T; Janszky J; Zambo K; Kovacs N
    Parkinsonism Relat Disord; 2016 Aug; 29():24-9. PubMed ID: 27290659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
    Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
    Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
    Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
    Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.